DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Penicillin G (Penicillin G Potassium) - Summary

 

-- advertisement --

PENICILLIN G SUMMARY

Penicillin G Potassium, USP is a natural penicillin.

Therapy

Penicillin G Potassium Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. Therapy with Penicillin G Potassium Injection, USP may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below; however, once these results become available, appropriate therapy should be continued.

CLINICAL INDICATION INFECTING ORGANISM
Septicemia, empyema, pneumonia, pericarditis, endocarditis, meningitis Streptococcus pyogenes (group A β-hemolytic streptococcus), other β-hemolytic streptococci including groups C, H, G, L and M, Streptococcus pneumoniae and Staphylococcus species (non-penicillinase producing strains)

Anthrax Bacillus anthracis

Actinomycosis (cervico-facial disease and thoracic and abdominal disease)

Actinomyces israelii

Botulism (adjunctive therapy to antitoxin), gas gangrene, and tetanus (adjunctive therapy to human tetanus immune globulin)

Clostridium species
Diphtheria (adjunctive therapy to antitoxin and prevention of the carrier state)

Corynebacterium diphtheriae
Erysipelothrix endocarditis Erysipelothrix rhusiopathiae

Fusospirochetosis (severe infections of the oropharynx [Vincent’s], lower respiratory tract and genital area)

Fusobacterium species and spirochetes
Listeria infections including meningitis and endocarditis

Listeria monocytogenes
Pasteurella infections including bacteremia and meningitis

Pasteurella multocida
Haverhill fever

Streptobacillus moniliformis
Rat bite fever Spirillum minus or Streptobacillus moniliformis

Disseminated gonococcal infections

Neisseria gonorrhoeae (penicillin-susceptible)
Syphilis (congenital and neurosyphilis)

Treponema pallidum
Meningococcal meningitis and/or septicemia

Neisseria meningitides
Gram-negative bacillary infections (bacteremias) Escherichia coli, Enterobacter aerogenes, Alcaligenes faecalis, salmonella , shigella and Proteus mirabilis, Penicillin G is not the drug of choice in the treatment of gram-negative bacillary infections.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Penicillin G Potassium Injection, USP and other antibacterial drugs, Penicillin G Potassium Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

PENICILLIN G NEWS HIGHLIGHTS

Media Articles Related to Penicillin G

penicillin g benzathine-injection, Bicillin L-A
Source: MedicineNet Yaws Specialty [2005.03.02]

more>>

Published Studies Related to Penicillin G

Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. [2008.06]

Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. [2008.02]

Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial. [2007.12]

Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia. [2006.04]

Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. [2006.03]

more>>

Clinical Trials Related to Penicillin G

Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin [Terminated]

TELI TON - Telithromycin in Tonsillitis [Terminated]

A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals [Completed]

TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults [Terminated]

Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis [Terminated]

more>>

Page last updated: 2008-06-22

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008